A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
University of Chicago
University of Chicago
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center
St. Jude Children's Research Hospital
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Gustave Roussy, Cancer Campus, Grand Paris
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
Stanford University
University of Chicago
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ruijin Hospital
Institute of Hematology & Blood Diseases Hospital, China
Goethe University
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Baylor College of Medicine
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
University of Cologne
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
University of Miami
International Extranodal Lymphoma Study Group (IELSG)
Therapeutic Advances in Childhood Leukemia Consortium
Dana-Farber Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Peking Union Medical College Hospital
Instituto do Cancer do Estado de São Paulo